Acute migraine headache Impel NeuroPharma

Impel NeuroPharma doses first patient in Phase lll trial of INP104

Impel NeuroPharma has dosed the first patient in the Phase lll Safety and Tolerability of POD-DHE (STOP-301) trial to investigate…